{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:02:01Z","timestamp":1776747721088,"version":"3.51.2"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s13312-025-00005-9","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T13:50:59Z","timestamp":1741873859000},"page":"181-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic and Prognostic Performance of Proadrenomedullin Versus Procalcitonin in Children with Cancer and Febrile Neutropenia"],"prefix":"10.1007","volume":"62","author":[{"given":"Jagdish Prasad","family":"Meena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshita","family":"Makkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashutosh","family":"Halder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachna","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"5_CR1","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/pbc.24485","volume":"60","author":"M Fletcher","year":"2013","unstructured":"Fletcher M, Hodgkiss H, Zhang S, et al. Prompt administration of antibiotics is associated with improved outcomes in febrile neutropenia in children with cancer. Pediatr Blood Cancer. 2013;60:1299\u2013306.","journal-title":"Pediatr Blood Cancer"},{"key":"5_CR2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0025-7125(16)30057-8","volume":"79","author":"H Giamarellou","year":"1995","unstructured":"Giamarellou H. Empiric therapy for infections in the febrile, neutropenic, compromised host. Med Clin North Am. 1995;79:559\u201380.","journal-title":"Med Clin North Am"},{"key":"5_CR3","doi-asserted-by":"crossref","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, et al. Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis Off Publ Infect Dis Soc Am. 2011;52:e56\u201393.","DOI":"10.1093\/cid\/cir073"},{"key":"5_CR4","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1086\/427330","volume":"40","author":"KA Sepkowitz","year":"2005","unstructured":"Sepkowitz KA. Treatment of patients with hematologic neoplasm, fever, and neutropenia. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;40:S253\u20136.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"5_CR5","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1080\/10428190802258956","volume":"49","author":"C Prat","year":"2008","unstructured":"Prat C, Sancho JM, Dominguez J, et al. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma. 2008;49:1752\u201361.","journal-title":"Leuk Lymphoma"},{"key":"5_CR6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jinf.2010.03.016","volume":"60","author":"M Limper","year":"2010","unstructured":"Limper M, de Kruif MD, Duits AJ, Brandjes DPM, van Gorp ECM. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect. 2010;60:409\u201316.","journal-title":"J Infect"},{"key":"5_CR7","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","volume":"35","author":"T Lehrnbecher","year":"2017","unstructured":"Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the Management of Fever and Neutropenia in Children with Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35:2082\u201394.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"5_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00043426-200201000-00011","volume":"24","author":"SW Alexander","year":"2002","unstructured":"Alexander SW, Wade KC, Hibberd PL, Parsons SK. Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2002;24:38\u201342.","journal-title":"J Pediatr Hematol Oncol"},{"key":"5_CR9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s13312-015-0566-5","volume":"52","author":"V Khadilkar","year":"2015","unstructured":"Khadilkar V, Yadav S, Agrawal KK, et al. Indian Academy of Pediatrics Growth Charts Committee, Revised IAP growth charts for height, weight and body mass index for 5- to 18-year-old Indian children. Indian Pediatr. 2015;52:47\u201355.","journal-title":"Indian Pediatr"},{"key":"5_CR10","doi-asserted-by":"crossref","unstructured":"Group WMGRS, de Onis M. WHO Child Growth Standards Based on Length\/Height, Weight and age. Acta Paediatr, 2006;95:76\u201385.","DOI":"10.1111\/j.1651-2227.2006.tb02378.x"},{"key":"5_CR11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1086\/342064","volume":"35","author":"ME Santolaya","year":"2002","unstructured":"Santolaya ME, Alvarez AM, Avil\u00e9s CL, et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis Off Publ Infect Dis Soc Am. 2002;35:678\u201383.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"5_CR12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/08880018.2015.1057310","volume":"32","author":"M Demirkaya","year":"2015","unstructured":"Demirkaya M, Tugcu D, Akcay A, et al. Adrenomedullin\u2013a new marker in febrile neutropenia: comparison with crp and procalcitonin. Pediatr Hematol Oncol. 2015;32:482\u20139.","journal-title":"Pediatr Hematol Oncol"},{"key":"5_CR13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MPH.0000000000001896","volume":"42","author":"JP Meena","year":"2020","unstructured":"Meena JP, Gupta AK, Seth R. Outcomes of febrile neutropenia in children with cancer managed on an outpatient basis: a report from tertiary care hospital from a resource-limited setting. J Pediatr Hematol Oncol. 2020;42:467\u201373.","journal-title":"J Pediatr Hematol Oncol"},{"key":"5_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.idc.2014.01.006","volume":"28","author":"OM Ibrahim","year":"2014","unstructured":"Ibrahim OM, Polk RE. Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am. 2014;28:195\u2013214.","journal-title":"Infect Dis Clin North Am"},{"key":"5_CR15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cis1029","volume":"56","author":"M Al Shuaibi","year":"2013","unstructured":"Al Shuaibi M, Bahu RR, Chaftari A-M, et al. Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Dis. 2013;56:943\u201350.","journal-title":"Clin Infect Dis"},{"key":"5_CR16","first-page":"539","volume":"23","author":"M von Lilienfeld-Toal","year":"2004","unstructured":"von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis. 2004;23:539\u201344.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5_CR17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1309\/AJCP1MFYINQLECV2","volume":"135","author":"S Riedel","year":"2011","unstructured":"Riedel S, Melendez JH, An AT, Rosenbaum JE, Zenilman JM. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol. 2011;135:182\u20139.","journal-title":"Am J Clin Pathol"},{"key":"5_CR18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s15010-007-7065-0","volume":"35","author":"P Schuetz","year":"2007","unstructured":"Schuetz P, Mueller B, Trampuz A. Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection. 2007;35:352\u20135.","journal-title":"Infection"},{"key":"5_CR19","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1086\/320744","volume":"32","author":"EJ Giamarellos-Bourboulis","year":"2001","unstructured":"Giamarellos-Bourboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;32:1718\u201325.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"5_CR20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12879-015-1095-5","volume":"15","author":"G Alcoba","year":"2015","unstructured":"Alcoba G, Manzano S, Lacroix L, Galetto-Lacour A, Gervaix A. Proadrenomedullin and copeptin in pediatric pneumonia: a prospective diagnostic accuracy study. BMC Infect Dis. 2015;15:347.","journal-title":"BMC Infect Dis"},{"key":"5_CR21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/labmed\/lmab002","volume":"52","author":"K Ar\u0131kan","year":"2021","unstructured":"Ar\u0131kan K, Karadag-Oncel E, Aytac S, et al. Usage of plasma presepsin, c-reactive protein, procalcitonin and proadrenomedullin to predict bacteremia in febril neutropenia of pediatric hematological malignancy patients. Lab Med. 2021;52:477\u201384.","journal-title":"Lab Med"},{"key":"5_CR22","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1097\/CCM.0000000000000526","volume":"42","author":"L Debiane","year":"2014","unstructured":"Debiane L, Hachem RY, Al Wohoush I, et al. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer. Crit Care Med. 2014;42:2500.","journal-title":"Crit Care Med"},{"key":"5_CR23","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00134-009-1610-5","volume":"35","author":"C Guignant","year":"2009","unstructured":"Guignant C, Voirin N, Venet F, et al. Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med. 2009;35:1859\u201367.","journal-title":"Intensive Care Med"}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-025-00005-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13312-025-00005-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-025-00005-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T03:09:10Z","timestamp":1742872150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13312-025-00005-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["5"],"URL":"https:\/\/doi.org\/10.1007\/s13312-025-00005-9","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"21 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ref No. IEC-459\/01.09.2027, RP-09\/2017, OP-13\/06.12.2019, RP-43\/2019, dated Dec 17, 2019.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}